HALO logo
halo search icon
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc.
PMCB · NAS

PharmaCyte Biotech, Inc.

US$0.77

Price Arrow0.036 (4.94%)
20/05/2026 03:59:16 PM
All-CompaniesHALO AllHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PharmaCyte Biotech, Inc. Overview

PMCB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PMCB

icon

Website

PharmaCyte Biotech, Inc.

icon

Telephone

1.917.595.2850

icon

Address

Suite 500, 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Description

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

PMCB Price Chart

Key Stats

Market Cap

US$7.86M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.63 - 1.51

Trade Value (12mth)

US$255,470.00

1 week

-9%

1 month

-4.94%

YTD

-0.81%

1 year

-29.72%

All time high

1250.06

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

0.00%

Operating Cashflow

N/A

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

9m

HALO Sector

Healthcare

Next Company Report Date

01-Jul-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PMCB Announcements

Latest Announcements

DateAnnouncements
03 April 26
28 January 26
28 January 26
28 January 26
19 December 25

PMCB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.83.19N/Alocklocklock
EPS (Fully Diluted)
$locklocklocklock-1.83.19N/Alocklocklock
Growth
%locklocklocklock-712.2277.2N/Alocklocklock
PE
XlocklocklocklockN/A0.4N/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of PharmaCyte Biotech, Inc. (PMCB:NAS)?
Halo FAQ
The current share price of PharmaCyte Biotech, Inc. (PMCB:NAS) is USD$0.77.
What is the 52-week high share price for PharmaCyte Biotech, Inc. (PMCB:NAS)?
Halo FAQ
The 52-week high share price for PharmaCyte Biotech, Inc. (PMCB:NAS) is USD$1.51.
What is the 52-week low share price for PharmaCyte Biotech, Inc. (PMCB:NAS)?
Halo FAQ
The 52-week low share price for PharmaCyte Biotech, Inc. (PMCB:NAS) is USD$0.63.
What is the dividend yield for PharmaCyte Biotech, Inc. (PMCB:NAS)?
Halo FAQ
PharmaCyte Biotech, Inc. (PMCB:NAS) does not pay a dividend.
What was PharmaCyte Biotech, Inc. (PMCB:NAS) last dividend payment?
Halo FAQ
PharmaCyte Biotech, Inc. (PMCB:NAS) does not pay a dividend.
What is the franking level for PharmaCyte Biotech, Inc. (PMCB:NAS)?
Halo FAQ
PharmaCyte Biotech, Inc. (PMCB:NAS) has a franking level of 0.00%.
In which sector is PharmaCyte Biotech, Inc. (PMCB:NAS) classified?
Halo FAQ
PharmaCyte Biotech, Inc. (PMCB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.